Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W. Thomas Chalberg


  • Chief Executive Officer at Avalanche Biotechnologies Inc. ([AAVL]), 2015-06-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
[AAVL] $38.90 6,995 Officer, Director 258,988 2015-06-10 Filing
[AAVL] $38.04 12,970 Officer, Director 265,983 2015-06-10 Filing
[AAVL] $36.89 5,035 Officer, Director 278,953 2015-06-10 Filing
AAVL $30.00 25,000 Officer, Director 283,988 2015-05-05 Filing
AAVL $55.46 85,000 Officer, Director 285,988 2015-01-13 Filing